Constantine Davides
Stock Analyst at JMP Securities
(1.24)
# 3,742
Out of 4,876 analysts
102
Total ratings
37.63%
Success rate
-19%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Reiterates: Market Outperform | $13 | $11.16 | +16.49% | 9 | Jun 20, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $115.12 | +30.30% | 3 | Jun 20, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $16.86 | - | 2 | Jun 18, 2025 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 | $32.25 | +11.63% | 5 | Jun 18, 2025 | |
| HQY HealthEquity | Maintains: Market Outperform | $110 → $117 | $104.88 | +11.56% | 5 | Jun 4, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $11 → $14 | $13.64 | +2.64% | 8 | May 13, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $11.38 | - | 3 | May 6, 2025 | |
| PRVA Privia Health Group | Reiterates: Market Outperform | $29 | $22.00 | +31.82% | 4 | Apr 28, 2025 | |
| AGL agilon health | Reiterates: Market Perform | n/a | $2.31 | - | 4 | Apr 28, 2025 | |
| USPH U.S. Physical Therapy | Reiterates: Market Outperform | $113 | $79.05 | +42.95% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $10.50 | +147.62% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $217.78 | +13.88% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $34 → $33 | $20.88 | +58.05% | 10 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $27.54 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $12.79 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.89 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.40 | +275.00% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $1.32 | +9,369.70% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $21.99 | -31.79% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $19.96 | +12.73% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $2.41 | +252.70% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.13 | +1,138.94% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $4.50 | +7,900.00% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $4.58 | +70,642.36% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.76 | +5,170.09% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.84 | +616.25% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $80 | $1.01 | +7,820.79% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $0.02 | +86,480.09% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.94 | +8,956.04% | 2 | Sep 23, 2022 |
Evolent Health
Jun 20, 2025
Reiterates: Market Outperform
Price Target: $13
Current: $11.16
Upside: +16.49%
Addus HomeCare
Jun 20, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $115.12
Upside: +30.30%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $16.86
Upside: -
Option Care Health
Jun 18, 2025
Reiterates: Market Outperform
Price Target: $36
Current: $32.25
Upside: +11.63%
HealthEquity
Jun 4, 2025
Maintains: Market Outperform
Price Target: $110 → $117
Current: $104.88
Upside: +11.56%
OptimizeRx
May 13, 2025
Maintains: Market Outperform
Price Target: $11 → $14
Current: $13.64
Upside: +2.64%
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.38
Upside: -
Privia Health Group
Apr 28, 2025
Reiterates: Market Outperform
Price Target: $29
Current: $22.00
Upside: +31.82%
agilon health
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $2.31
Upside: -
U.S. Physical Therapy
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $79.05
Upside: +42.95%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $10.50
Upside: +147.62%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $217.78
Upside: +13.88%
Feb 24, 2025
Maintains: Market Outperform
Price Target: $34 → $33
Current: $20.88
Upside: +58.05%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $27.54
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $12.79
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $21.89
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.40
Upside: +275.00%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $1.32
Upside: +9,369.70%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $21.99
Upside: -31.79%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $19.96
Upside: +12.73%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.41
Upside: +252.70%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.13
Upside: +1,138.94%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $4.50
Upside: +7,900.00%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $4.58
Upside: +70,642.36%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.76
Upside: +5,170.09%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.84
Upside: +616.25%
Sep 28, 2022
Maintains: Buy
Price Target: $140 → $80
Current: $1.01
Upside: +7,820.79%
Sep 28, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $0.02
Upside: +86,480.09%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.94
Upside: +8,956.04%